NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Denali Therapeutics (DNLI)

Technical Analysis Report for NASDAQ stock DNLI Denali Therapeutics. Dated: 12 May 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock DNLI Denali Therapeutics then click here. or read Experts views on Denali Therapeutics or Forecast & share price targets of Denali Therapeutics

Denali Therapeutics Opened at 19.76 and Closed at: 19.46, which is -1.13% of previous session's close. It moved within a range of 19.17 and 19.97
The session was a Bearish session with an average volume of 1792300, which is 19.43% of previous session's volumes.

• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

Support for tomorrow is 18.92 and resistance for tomorrow is 19.72
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 19.1, 18.73 resistance for tomorrow's hourly charts is 19.9, 20.33

10 Day SMA for Denali Therapeutics (DNLI) is 19.39 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Denali Therapeutics (DNLI) is 19.7 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Denali Therapeutics (DNLI) is 19.98 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 19.56 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Denali Therapeutics is 17.67 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Denali Therapeutics is at 19.7 and 200 DMA is at 17.67, while 50 DMA and 100 DMA are at 19.98 and 19.56 respectively

Denali Therapeutics (DNLI) moving average of 20 SMA is at 19.7 and 20 EMA is at 19.65

Denali Therapeutics (DNLI) moving average of 50 SMA is at 19.98 and 50 EMA is at 19.78

Denali Therapeutics (DNLI) moving average of 100 SMA is at 19.56 and 100 EMA is at 19.36

Denali Therapeutics (DNLI) moving average of 200 SMA is at 17.67 and 200 EMA is at 18.79

Vertex Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 8.93% more returns!

Therapeuticsmd Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 1.71% more returns!

Denali Therapeutics has performed better than Sarepta Therapeutics in short term. Holding Denali Therapeutics could be a better choice for now!

Denali Therapeutics has performed better than Summit Therapeutics in short term. Holding Denali Therapeutics could be a better choice for now!

Surgery Partners has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 10.06% more returns!

Pro Dex has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Pro Dex, about 13.45% more returns!

Denali Therapeutics has performed better than Outlook Therapeutics in short term. Holding Denali Therapeutics could be a better choice for now!

Denali Therapeutics has performed better than Opko Health in short term. Holding Denali Therapeutics could be a better choice for now!

Moderna Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 3.41% more returns!

Kiniksa Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 37.28% more returns!

Fulgent Genetics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Fulgent Genetics, about 3.99% more returns!

Catalyst Biosciences has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 0.95% more returns!

Bioxcel Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Bioxcel Therapeutics, about 17.15% more returns!

Autolus Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 6.04% more returns!

Denali Therapeutics has performed better than Ac Immune in short term. Holding Denali Therapeutics could be a better choice for now!

Denali Therapeutics Technical analysis of indicators

Price action analysis of Denali Therapeutics (DNLI) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

ADX buy sell signal for Denali Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Denali Therapeutics in short term but the buy signal is initial and weak.

Denali Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Denali Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Denali Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 19.31 and Denali Therapeutics DNLI stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Denali Therapeutics DNLI stock. Volume based technical analysis of Denali Therapeutics DNLI stock is negative.

Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock DNLI Denali Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And DNLI Experts View which covers a lot of information including buying and selling signals

DNLI future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Denali Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet